Net Cash Provided by (Used in) Operating Activities |
1.33B |
USD |
-6.39% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
-269M |
USD |
-4.67% |
Q1 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-751M |
USD |
+41.3% |
Q1 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
400M |
shares |
0% |
Q2 2024 |
Q2 2024 |
Common Stock, Shares, Issued |
178M |
shares |
-0.46% |
Q2 2024 |
Q2 2024 |
Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q2 2024 |
Q2 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
314M |
USD |
|
Q1 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
6.91B |
USD |
+32810% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Valuation Allowance |
233M |
USD |
+4.48% |
Q4 2023 |
FY 2023 |
Deferred Tax Assets, Gross |
456M |
USD |
-20.8% |
Q4 2023 |
FY 2023 |
Deferred Income Tax Expense (Benefit) |
52M |
USD |
-46.4% |
Q1 2024 |
Q1 2024 |
Deferred Tax Assets, Operating Loss Carryforwards |
236M |
USD |
-41.9% |
Q4 2023 |
FY 2023 |
Unrecognized Tax Benefits |
0 |
USD |
-100% |
Q4 2023 |
FY 2023 |
Depreciation, Depletion and Amortization |
1.86B |
USD |
+21.3% |
Q2 2024 |
Q2 2024 |
Deferred Tax Assets, Net of Valuation Allowance |
223M |
USD |
-36.8% |
Q4 2023 |
FY 2023 |